
Volixibat potassium
CAS No. 1431935-92-0
Volixibat potassium( SHP-626 | SAR-548304 | LUM-002 )
Catalog No. M11837 CAS No. 1431935-92-0
A highly potent and selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT) in development for the treatment of nonalcoholic steatohepatitis (NASH).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameVolixibat potassium
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent and selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT) in development for the treatment of nonalcoholic steatohepatitis (NASH).
-
DescriptionA highly potent and selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT) in development for the treatment of nonalcoholic steatohepatitis (NASH).Steatohepatitis Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsSHP-626 | SAR-548304 | LUM-002
-
PathwayMembrane Transporter/Ion Channel
-
TargetASBT Transporter
-
RecptorASBT Transporter
-
Research AreaOther Indications
-
IndicationSteatohepatitis
Chemical Information
-
CAS Number1431935-92-0
-
Formula Weight844.045
-
Molecular FormulaC38H50KN3O12S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name((2R,3R,4S,5R,6R)-4-(benzyloxy)-6-(3-(3-((3S,4R,5R)-3-butyl-7-(dimethylamino)-3-ethyl-4-hydroxy-1,1-dioxido-2,3,4,5-tetrahydrobenzo[b]thiepin-5-yl)phenyl)ureido)-3,5-dihydroxytetrahydro-2H-pyran-2-yl)methyl hydrogen sulfate, potassium salt
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Siebers N, et al. Eur J Drug Metab Pharmacokinet. 2017 Jul 12. doi: 10.1007/s13318-017-0429-7.
2. Tiessen RG, et al. BMC Gastroenterol. 2018 Jan 5;18(1):3.
molnova catalog



related products
-
Volixibat potassium
A highly potent and selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT) in development for the treatment of nonalcoholic steatohepatitis (NASH).
-
Lopixibat chloride
Lopixibat chloride (LUM-001, HP-625) is a potent, selectiove, oral inhibitor of sodium bile acid cotransporter and Ileal bile acid transporter (IBAT).
-
A4250
A4250 (A-4250, Odevixibat) is a small molecule ileal bile acid transporter (IBAT) inhibitor for the treatment of cholestatic liver diseases including progressive familial intrahepatic cholestasis and NASH.